.png)
The Drug Administration Department of Karnataka has withdrawn defective medications totaling Rs 24.3 lakh from the market as part of a campaign against subpar pharmaceuticals.
.png)
The USFDA has approved the cancer treatment medication Jobevne, which has allowed Biocon Biologics, the biosimilar division of Biocon, to increase its oncology portfolio.
In order to prevent the sales of unapproved or illegal medicines in Indian market, import registration and license have been made mandatory by The Central Drugs Standard Control Organization. On April 8, the apex drug regulatory agency of India...
Donald Trump's remarks threatening massive tariffs on all imports of pharmaceuticals led to a crash in the Indian pharmaceutical stocks. The news unsettled the Indian...
.png)
Lyka Labs Limited has revealed that it has received an Indian Patent for its unique product, Pregabalin Gel 8 percent, with patent protection lasting until 2043.
Industry leaders want the Indian government to undertake an entire impact and vulnerability study to identify the risk associated with importing...
AstraZeneca Pharma India Limited has received the authorization from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import and market Osimertinib Tablets 40 mg & 80 mg....
In India's medical device industry, the Gujarat government's recent plan to impose a separate pricing system for drug-eluting stents (DES) has sparked controversy. The new regulation sets the price of stents that have been approved by the US Food....
The 'reciprocal tariff' plans of US President Donald Trump do not cover pharmaceuticals, thus, emphasizing the significance of...
India's medical device sector stands to benefit from shifting trade dynamics, especially with the introduction of recent tariffs by the US that reduce the...
, CDSCO.jpg)
